DuPont de Nemours acquires Donatelle Plastics
Snapshot
DuPont de Nemours acquired Donatelle Plastics for $365 million net purchase price (including a contingent earn-out liability with an estimated fair value of $40 million) in July 2024. The transaction was structured as all cash plus contingent earn-out. Donatelle Plastics is a New Brighton, Minnesota, United States-based Electronics & Industrial — Industrial Solutions business.
- Acquirer
- DuPont de Nemours
- Target
- Donatelle Plastics
- Value
- $365 million net purchase price (including a contingent earn-out liability with an estimated fair value of $40 million)
- Date
- July 2024
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
DuPont de Nemours acquired Donatelle Plastics for $365 million net purchase price (including a contingent earn-out liability with an estimated fair value of $40 million), a transaction completed in July 2024, structured as all cash plus contingent earn-out.
Donatelle Plastics operates in Electronics & Industrial — Industrial Solutions, is based in New Brighton, Minnesota, United States. Donatelle Plastics, LLC is a medical-device company specializing in the design, development and manufacture of medical components and devices, headquartered in New Brighton, Minnesota. DuPont integrated it into Industrial Solutions within the Electronics & Industrial segment, alongside its existing healthcare offerings including Spectrum and Liveo. The FY24 10-K records a net purchase price of $365 million, which includes the estimated fair value of a $40 million contingent earn-out liability.
Donatelle Plastics will be the second acquisition that will deepen our expertise in the medical device market segments.
A second medical-device contract manufacturer that deepens DuPont's expertise in medical-device market segments and builds scale in healthcare alongside Spectrum and Liveo. Combines with Spectrum and Liveo healthcare offerings within Industrial Solutions. Industrial Solutions within the Electronics & Industrial segment
No advisory firms have been disclosed for this transaction.